These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 29274236

  • 1. Successful steroid withdrawal guided by surveillance biopsies-A single-center experience.
    Wehmeier C, Hirt-Minkowski P, Amico P, Georgalis A, Hopfer H, Steiger J, Dickenmann M, Schaub S.
    Clin Transplant; 2018 Mar; 32(3):e13181. PubMed ID: 29274236
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.
    Di Vico MC, Messina M, Fop F, Barreca A, Segoloni GP, Biancone L.
    Clin Transplant; 2018 Apr; 32(4):e13207. PubMed ID: 29345747
    [Abstract] [Full Text] [Related]

  • 5. Ten-year observational follow-up of a randomized trial comparing cyclosporine and tacrolimus therapy combined with steroid withdrawal in living-donor renal transplantation.
    Kim J, Park J, Hwang S, Yoo H, Kim K, Park JB, Jang HR, Lee JE, Kim SJ, Kim YG, Kim DJ, Oh HY, Huh W.
    Clin Transplant; 2018 Sep; 32(9):e13372. PubMed ID: 30080284
    [Abstract] [Full Text] [Related]

  • 6. Racial disparity in kidney transplant survival relates to late rejection and is independent of steroid withdrawal.
    Liu A, Woodside KJ, Augustine JJ, Sarabu N.
    Clin Transplant; 2018 Sep; 32(9):e13381. PubMed ID: 30098053
    [Abstract] [Full Text] [Related]

  • 7. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y, Tojimbara T, Iwadoh K, Koyama I, Nanmoku K, Kai K, Sannomiya A, Nakajima I, Fuchinoue S, Teraoka S.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1984-92. PubMed ID: 17161352
    [Abstract] [Full Text] [Related]

  • 8. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 20; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 9. Steroid withdrawal in renal transplantation.
    Grenda R.
    Pediatr Nephrol; 2013 Nov 20; 28(11):2107-12. PubMed ID: 23288351
    [Abstract] [Full Text] [Related]

  • 10. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Ferreira A, Felipe C, Cristelli M, Viana L, Basso G, Stopa S, Mansur J, Ivani M, Bessa A, Ruppel P, Aguiar W, Campos E, Gerbase-DeLima M, Proença H, Tedesco-Silva H, Medina-Pestana J.
    Am J Nephrol; 2017 Nov 20; 45(6):497-508. PubMed ID: 28511172
    [Abstract] [Full Text] [Related]

  • 11. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
    Montini G, Murer L, Ghio L, Pietrobon B, Ginevri F, Ferraresso M, Cardillo M, Scalamogna M, Perfumo F, Edefonti A, Zanon GF, Zacchello G.
    Transpl Int; 2005 Jan 20; 18(1):36-42. PubMed ID: 15612981
    [Abstract] [Full Text] [Related]

  • 12. Late Steroid Withdrawal Following AB0-Incompatible Renal Transplantation.
    Bachmann F, Lachmann N, Budde K, Liefeldt L, Halleck F, Naik M, Friedersdorff F, Rudolph B, Wu K, Meyer O, Slowinski T, Waiser J.
    Transplant Proc; 2018 Jan 20; 50(1):72-78. PubMed ID: 29407335
    [Abstract] [Full Text] [Related]

  • 13. A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients.
    Taber DJ, Hunt KJ, Gebregziabher M, Srinivas T, Chavin KD, Baliga PK, Egede LE.
    Clin J Am Soc Nephrol; 2017 Jan 06; 12(1):131-139. PubMed ID: 27979979
    [Abstract] [Full Text] [Related]

  • 14. Impact of the addition of maintenance steroids to a rapid steroid discontinuation immunosuppressive protocol following acute renal transplant rejection.
    Arora S, Marcus RJ, Dikkala S, Sureshkumar KK.
    Exp Clin Transplant; 2009 Dec 06; 7(4):233-6. PubMed ID: 20353373
    [Abstract] [Full Text] [Related]

  • 15. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant.
    Pascual J, van Hooff JP, Salmela K, Lang P, Rigotti P, Budde K.
    Transplantation; 2006 Jul 15; 82(1):55-61. PubMed ID: 16861942
    [Abstract] [Full Text] [Related]

  • 16. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H, Haussman G, Isaacs I, Ishitani M, Lobo P, McCullough C, Pruett T.
    Clin Transplant; 1997 Oct 15; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [Abstract] [Full Text] [Related]

  • 17. Short-term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocol.
    Mehta R, Bhusal S, Randhawa P, Sood P, Cherukuri A, Wu C, Puttarajappa C, Hoffman W, Shah N, Mangiola M, Zeevi A, Tevar AD, Hariharan S.
    Am J Transplant; 2018 Jul 15; 18(7):1710-1717. PubMed ID: 29247472
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
    Hussain SM, Marcus RJ, Ko TY, Nashar K, Thai NL, Sureshkumar KK.
    Exp Clin Transplant; 2016 Jun 15; 14(3):287-93. PubMed ID: 27221720
    [Abstract] [Full Text] [Related]

  • 19. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology.
    Stevens RB, Foster KW, Miles CD, Kalil AC, Florescu DF, Sandoz JP, Rigley TH, Malik T, Wrenshall LE.
    PLoS One; 2015 Jun 15; 10(10):e0139247. PubMed ID: 26465152
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.
    Krämer BK, Klinger M, Vítko Š, Glyda M, Midtvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Ostrowski M, Senatorski G, Nordström J, Salmela K.
    Transplantation; 2012 Sep 15; 94(5):492-8. PubMed ID: 22858806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.